We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
CONMED
CNMD
$1.41B
| $1.42M | 0.01% |
27,940
+3,400
| +14% | +$168K |
|
|
CMRX
827
DELISTED
Chimerix, Inc.
CMRX
| $1.41M | 0.01% |
258,573
+191,400
| +285% | +$1.01M |
|
828
The RMR Group
RMR
$327M
| $1.4M | 0.01% |
28,799
+9,300
| +48% | +$469K |
|
|
IPHS
829
DELISTED
Innophos Holdings, Inc.
IPHS
| $1.4M | 0.01% |
31,900
-1,000
| -3% | -$44.9K |
|
830
Expeditors International
EXPD
$25.2B
| $1.38M | 0.01% |
24,391
-11,700
| -32% | -$644K |
|
|
CHS
831
DELISTED
Chicos FAS, Inc.
CHS
| $1.37M | 0.01% |
145,110
-72,490
| -33% | -$837K |
|
832
Invesco CurrencyShares Euro Currency Trust
FXE
$357M
| $1.36M | 0.01% |
12,342
| – | – |
|
833
Cousins Properties
CUZ
$4.6B
| $1.36M | 0.01% |
38,771
+4,250
| +12% | +$146K |
|
834
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.5B
| $1.35M | 0.01% |
27,496
-7,550
| -22% | -$373K |
|
835
iShares MSCI New Zealand ETF
ENZL
$74.2M
| $1.34M | 0.01% |
28,900
-1,800
| -6% | -$78.9K |
|
836
Rogers Communications
RCI
$19.4B
| $1.31M | 0.01% |
27,848
+500
| +2% | +$23.1K |
|
|
BOJA
837
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $1.31M | 0.01% |
+80,500
| New | +$1.48M |
|
838
Bright Horizons
BFAM
$3.28B
| $1.31M | 0.01% |
16,925
| – | – |
|
839
Crawford & Co Class B
CRD.B
$554M
| $1.3M | 0.01% |
139,915
+29,882
| +27% | +$290K |
|
|
SRG
840
Seritage Growth Properties
SRG
$113M
| $1.3M | 0.01% |
31,000
+9,000
| +41% | +$373K |
|
|
ABCO
841
DELISTED
Advisory Board Co
ABCO
| $1.3M | 0.01% |
25,229
| – | – |
|
842
Johnson Outdoors
JOUT
$467M
| $1.28M | 0.01% |
26,617
+7,756
| +41% | +$323K |
|
843
VeriSign
VRSN
$26.9B
| $1.28M | 0.01% |
13,753
-3,700
| -21% | -$334K |
|
844
Franklin Templeton
BEN
$16.9B
| $1.28M | 0.01% |
28,505
-10,252
| -26% | -$438K |
|
845
Ceco Environmental
CECO
$3.95B
| $1.28M | 0.01% |
139,000
| – | – |
|
|
CSR
846
Centerspace
CSR
$972M
| $1.27M | 0.01% |
20,524
| – | – |
|
847
Banco Santander Chile
BSAC
$16.4B
| $1.27M | 0.01% |
50,000
| – | – |
|
848
Quantum Corp
QMCO
$917M
| $1.27M | 0.01% |
+8,110
| New | +$1.26M |
|
849
Koppers
KOP
$866M
| $1.26M | 0.01% |
35,000
-5,400
| -13% | -$208K |
|
|
DEA
850
Easterly Government Properties
DEA
$1.12B
| $1.26M | 0.01% |
+24,000
| New | +$1.23M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.